Author:
Balavarca Y,Pearce K,Norden J,Collin M,Jackson G,Holler E,Dressel R,Kolb H-J,Greinix H,Socie G,Toubert A,Rocha V,Gluckman E,Hromadnikova I,Sedlacek P,Wolff D,Holtick U,Dickinson A,Bickeböller H
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Reference60 articles.
1. Gratwohl A, Hermans J, Goldman JM, Arcese W, Carreras E, Devergie A et al. Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Lancet 1998; 352: 1087–1092.
2. Gratwohl A, Brand R, Apperley J, Crawley C, Ruutu T, Corradini P et al. Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia in Europe 2006: transplant activity, long-term data and current results. An analysis by the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Haematologica 2006; 91: 513–521.
3. Gratwohl A, Stern M, Brand R, Apperley J, Baldomero H, de Witte T et al. Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysis. Cancer 2009; 115: 4715–4726.
4. Gratwohl A . The EBMT risk score. Bone Marrow Transplant 2012; 47: 749–756.
5. Mullally A, Ritz J . Beyond HLA: the significance of genomic variation for allogeneic hematopoietic stem cell transplantation. Blood 2007; 109: 1355–1362.
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献